n-[6-(2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)-1-oxohexyl]-l-valyl-n5-(carbamoyl) preparation of -n-[4-(hydroxymethyl)phenyl]-l-ornithine amide_kain industrial additive
background and overview[1] n-[6-(2,5-dihydro-2,5-dioxo-1h-pyrrol-1-yl)-1-oxohexyl]-l-valyl-n5-(amino formyl)-n-[4-(hydroxymethyl)phenyl]-l-ornithine amide can be used to prepare antibody-drug conjugates. antibody drug conjugates (adcs), as a new type of targeted drugs, generally consist of three parts: antibodies or antibody-based ligands, small molecule drugs, and linkers that couple the ligands and drugs. antibody-conjugated drugs use the specific recognition of antigens by antibodies to…
